Allison L. Germann

645 total citations
34 papers, 489 citations indexed

About

Allison L. Germann is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Allison L. Germann has authored 34 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 31 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in Allison L. Germann's work include Neuroscience and Neuropharmacology Research (31 papers), Receptor Mechanisms and Signaling (24 papers) and Nicotinic Acetylcholine Receptors Study (16 papers). Allison L. Germann is often cited by papers focused on Neuroscience and Neuropharmacology Research (31 papers), Receptor Mechanisms and Signaling (24 papers) and Nicotinic Acetylcholine Receptors Study (16 papers). Allison L. Germann collaborates with scholars based in United States, Japan and Argentina. Allison L. Germann's co-authors include Gustav Akk, Joe Henry Steinbach, Daniel J. Shin, Alex S. Evers, Spencer R. Pierce, Douglas F. Covey, David E. Reichert, John Bracamontes, Kathiresan Krishnan and Wayland W.L. Cheng and has published in prestigious journals such as Scientific Reports, Biophysical Journal and PLoS Biology.

In The Last Decade

Allison L. Germann

32 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison L. Germann United States 13 374 351 47 42 35 34 489
Daniel J. Shin United States 9 238 0.6× 233 0.7× 27 0.6× 21 0.5× 19 0.5× 11 315
Guadalupe Rivero Spain 12 363 1.0× 365 1.0× 35 0.7× 20 0.5× 27 0.8× 23 523
Rosa Fradley United Kingdom 10 319 0.9× 222 0.6× 107 2.3× 29 0.7× 18 0.5× 13 490
Gopalan V. Pillai United Kingdom 10 501 1.3× 329 0.9× 24 0.5× 33 0.8× 30 0.9× 14 609
Jesús Garcı́a-Colunga Mexico 16 293 0.8× 476 1.4× 50 1.1× 35 0.8× 14 0.4× 42 682
M Assumpció Boronat Spain 9 404 1.1× 307 0.9× 34 0.7× 36 0.9× 21 0.6× 10 572
Sangeetha Iyer United States 11 175 0.5× 242 0.7× 19 0.4× 12 0.3× 12 0.3× 14 393
Anne B. Need United States 11 316 0.8× 237 0.7× 77 1.6× 16 0.4× 33 0.9× 15 529
Charles F. Zorumski United States 9 450 1.2× 379 1.1× 17 0.4× 32 0.8× 31 0.9× 10 553
Ruth M. McKernan United Kingdom 6 521 1.4× 396 1.1× 21 0.4× 45 1.1× 29 0.8× 8 613

Countries citing papers authored by Allison L. Germann

Since Specialization
Citations

This map shows the geographic impact of Allison L. Germann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison L. Germann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison L. Germann more than expected).

Fields of papers citing papers by Allison L. Germann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison L. Germann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison L. Germann. The network helps show where Allison L. Germann may publish in the future.

Co-authorship network of co-authors of Allison L. Germann

This figure shows the co-authorship network connecting the top 25 collaborators of Allison L. Germann. A scholar is included among the top collaborators of Allison L. Germann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison L. Germann. Allison L. Germann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Germann, Allison L., et al.. (2024). Comparison of Behavioral Effects of GABAergic Low- and High-Efficacy Neuroactive Steroids in the Zebrafish Larvae Assay. ACS Chemical Neuroscience. 15(5). 909–915. 1 indexed citations
2.
Pierce, Spencer R., Allison L. Germann, Douglas F. Covey, et al.. (2024). Inhibitory Actions of Potentiating Neuroactive Steroids in the Human α1β3γ2L γ-Aminobutyric Acid Type A Receptor. Molecular Pharmacology. 106(5). 264–277. 2 indexed citations
3.
Pierce, Spencer R., et al.. (2023). Potentiation of the GABAAR reveals variable energetic contributions by etiocholanolone and propofol. Biophysical Journal. 123(14). 1954–1967. 2 indexed citations
4.
5.
Pohl, Franziska, Allison L. Germann, Paul Kong Thoo Lin, et al.. (2023). UNC-49 is a redox-sensitive GABA A receptor that regulates the mitochondrial unfolded protein response cell nonautonomously. Science Advances. 9(44). eadh2584–eadh2584. 5 indexed citations
6.
Tateiwa, Hiroki, Ziwei Chen, Lei Wang, et al.. (2023). The Mechanism of Enantioselective Neurosteroid Actions on GABAA Receptors. Biomolecules. 13(2). 341–341. 12 indexed citations
7.
Arias, Hugo R., Cecilia M. Borghese, Allison L. Germann, et al.. (2022). (+)-Catharanthine potentiates the GABAA receptor by binding to a transmembrane site at the β(+)/α(-) interface near the TM2-TM3 loop. Biochemical Pharmacology. 199. 114993–114993. 4 indexed citations
8.
Akk, Gustav, Allison L. Germann, Yusuke Sugasawa, et al.. (2020). Enhancement of Muscimol Binding and Gating by Allosteric Modulators of the GABAA Receptor: Relating Occupancy to State Functions. Molecular Pharmacology. 98(4). 303–313. 10 indexed citations
9.
Sugasawa, Yusuke, Wayland W.L. Cheng, John Bracamontes, et al.. (2020). Site-specific effects of neurosteroids on GABAA receptor activation and desensitization. eLife. 9. 45 indexed citations
10.
Germann, Allison L., David E. Reichert, Spencer R. Pierce, et al.. (2020). Analysis of Modulation of the ρ1 GABAA Receptor by Combinations of Inhibitory and Potentiating Neurosteroids Reveals Shared and Distinct Binding Sites. Molecular Pharmacology. 98(4). 280–291. 4 indexed citations
11.
Chen, Zi-Wei, John Bracamontes, Melissa M. Budelier, et al.. (2019). Multiple functional neurosteroid binding sites on GABAA receptors. PLoS Biology. 17(3). e3000157–e3000157. 83 indexed citations
12.
Germann, Allison L., et al.. (2019). Steady-State Activation and Modulation of the Concatemeric α1β2γ2L GABAA Receptor. Molecular Pharmacology. 96(3). 320–329. 14 indexed citations
13.
Pierce, Spencer R., et al.. (2019). Steady-state activation of the high-affinity isoform of the α4β2δ GABAA receptor. Scientific Reports. 9(1). 15997–15997. 6 indexed citations
14.
Montana, Michael C., Allison L. Germann, Daniel J. Shin, et al.. (2018). Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam. Scientific Reports. 8(1). 10341–10341. 21 indexed citations
15.
Germann, Allison L., et al.. (2018). High Constitutive Activity Accounts for the Combination of Enhanced Direct Activation and Reduced Potentiation in Mutated GABAA Receptors. Molecular Pharmacology. 93(5). 468–476. 6 indexed citations
16.
Shin, Daniel J., Allison L. Germann, Douglas F. Covey, Joe Henry Steinbach, & Gustav Akk. (2018). Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites. Molecular Pharmacology. 95(1). 70–81. 29 indexed citations
17.
Teitelbaum, Aaron M., Sharon E. Murphy, Gustav Akk, et al.. (2017). Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. The Pharmacogenomics Journal. 18(1). 136–143. 12 indexed citations
18.
Shin, Daniel J., Allison L. Germann, Joe Henry Steinbach, & Gustav Akk. (2017). The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity. Molecular Pharmacology. 92(5). 556–563. 27 indexed citations
19.
Akk, Gustav, Daniel J. Shin, Allison L. Germann, & Joe Henry Steinbach. (2017). GABA Type A Receptor Activation in the Allosteric Coagonist Model Framework: Relationship between EC50 and Basal Activity. Molecular Pharmacology. 93(2). 90–100. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel J. Shin Breakdown of academic impact, for papers by Guadalupe Rivero Breakdown of academic impact, for papers by Rosa Fradley Breakdown of academic impact, for papers by Gopalan V. Pillai Breakdown of academic impact, for papers by Jesús Garcı́a-Colunga Breakdown of academic impact, for papers by M Assumpció Boronat Breakdown of academic impact, for papers by Sangeetha Iyer Breakdown of academic impact, for papers by Anne B. Need Breakdown of academic impact, for papers by Charles F. Zorumski Breakdown of academic impact, for papers by Ruth M. McKernan
Rankless by CCL
2026